Skip to main content
logo
Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
3.250
-0.270 (-7.67%)
At close: Aug 5, 2026, 4:00 PM EDT
3.290
+0.040 (1.23%)
Pre-market: Aug 6, 2026, 8:30 AM EDT

Aethlon Medical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-7.15-13.39-12.21-12.03-10.42
Depreciation & Amortization
0.320.340.360.240.12
Stock-Based Compensation
0.280.421.221.050.75
Other Adjustments
0.294.890.020.170.03
Change in Receivables
---0.130.02
Changes in Accounts Payable
-0.38-0.050.16-0.170.1
Changes in Unearned Revenue
----0.340.23
Changes in Other Operating Activities
-0.360.150.320.46-0.6
Operating Cash Flow
-7-7.65-10.13-10.51-9.77
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-0--0.25-0.94-0.35
Investing Cash Flow
-0--0.25-0.94-0.35

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Issuance of Common Stock
7.759.081.328.9317.46
Repurchase of Common Stock
-0.01-0.02-0.03-0.01-0.09
Net Common Stock Issued (Repurchased)
7.749.061.298.9117.37
Other Financing Activities
-1.22-1.33---
Financing Cash Flow
6.527.731.298.9117.37

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.01-0.010-0.01-
Net Cash Flow
-0.470.07-9.09-2.547.25

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-7-7.65-10.38-11.45-10.12
Free Cash Flow Growth
-----
FCF Margin
----1993.62%-3439.01%
Free Cash Flow Per Share
-51.95-244.92---
Levered Free Cash Flow
-7.57-12.95-11.62-12.79-10.91
Unlevered Free Cash Flow
-7.72-8.91-12.05-12.66-10.92
SEC Filings: 10-K · 10-Q